Authors: Plobeck, N Delorme, D Wei, ZY Yang, H Zhou, F Schwarz, P Gawell, L Gagnon, H Pelcman, B Schmidt, R Yue, SY Walpole, C Brown, W Zhou, E Labarre, M Payza, K St-Onge, S Kamassah, A Morin, PE Projean, D Ducharme, J Roberts, E

Citation: N. Plobeck et al., New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased in vitro metabolic stability, J MED CHEM, 43(21), 2000, pp. 3878-3894

Authors: Wei, ZY Brown, W Takasaki, B Plobeck, N Delorme, D Zhou, F Yang, H Jones, P Gawell, L Gagnon, H Schmidt, R Yue, SY Walpole, C Payza, K St-Onge, S Labarre, M Godbout, C Jakob, A Butterworth, J Kamassah, A Morin, PE Projean, D Ducharme, J Roberts, E

Citation: Zy. Wei et al., N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: A novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues, J MED CHEM, 43(21), 2000, pp. 3895-3905

Authors: Nicoll-Griffith, DA Falgueyret, JP Silva, JM Morin, PE Trimble, L Chan, CC Clas, S Leger, S Wang, ZY Yergey, JA Riendeau, D

Citation: Da. Nicoll-griffith et al., Oxidative bioactivation of the lactol prodrug of a lactone cyclooxygenase-2 inhibitor, DRUG META D, 27(3), 1999, pp. 403-409